Tipranavir + Loperamide = Precautionary

Effect on Concentration

Tipranavir
Unknown
Applies within class?
No
Loperamide
Decrease
Applies within class?
No

Pharmacologic Effects

Effect
N/A
Applies within class?
No
Effect
N/A
Applies within class?
No

Interaction History

N/A

Last Updated 22-Nov-2022

Summary

24 HIV negative subjects were randomized to assess the combination of loperamide (LOP) with either tipranavir 750mg BID (TPV), ritonavir 200mg BID (RTV), or TPV/RTV 750/200mg BID. LOP AUC decreased 51% and 63% with TPV and TPV/RTV, respectively while RTV increased the AUC of LOP 121%. However, the respiratory response to LOP was no different when LOP was combined with TPV or RTV as compared to LOP alone. Likewise, the combination of LOP with TPV/RTV was well tolerated.

Sources

Study Design

Study Results

Study Conclusions

References

Geoffrey Mukwaya, Thomas MacGregor, David Hoelscher, Thomas Heming, Daniel Legg, Kelli Kavanaugh, Phillip Johnson, John P Sabo, Scott McCallister. Interaction of ritonavir-boosted tipranavir with loperamide does not result in loperamide-associated neurologic side effects in healthy volunteers. Antimicrobial Agents And Chemotherapy. 2005; 12: 4903-4910.